DRS229520_1.png

Pagenax Solution for Injection

Therapeutic Class: OPHTHAL
Manufacturer:
Get Quote

Vascular endothelial growth factor (VEGF) is a protein that promotes the growth of new blood vessels. In certain eye diseases, abnormal blood vessels start growing under the retina, leading to fluid leakage, bleeding, and damage to the central part of the retina called the macula. This can result in severe vision loss and distortion of central vision. Pagenax Solution for Injection blocks the activity of the VEGF protein. By inhibiting VEGF, the medication reduces the growth and leakage of abnormal blood vessels in the retina.

Salt Composition: Brolucizumab (120mg/ml)
Strength: Brolucizumab (120mg/ml)
Pack Size: vial of 1 Solution for Injection
Uses: Treatment of Wet age-related macular degeneration
Table Header
Salt Composition
Brolucizumab (120mg/ml)
Strength
Brolucizumab (120mg/ml)
Pack Size
vial of 1 Solution for Injection
Uses
Treatment of Wet age-related macular degeneration
DISCLAIMER
Niche Formulations (www.nicheformulations.com) is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India. Product is supplied for Tenders/ Emergency imports/ Unlicensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials. Product names, logos, brands and other trademarks featured or referred to are the property of their respective Trademark Holders. The information provided here is for Informational purposes only.

Product information is meant for

WholesalersSuppliersExportersDoctorsMOH Tender SuppliesHospitalsBrandCROsComparator SuppliesGenericCooperate SourcingIndividual PatientsIndian Institutional Buyers
Recently Viewed
Categories
error:

Select at least 2 products
to compare